Enteral Glutamine Supplementation for Very-Low-Birth-Weight Infants Decreases Hospital Costs

Abstract

Background: There is growing evidence that glutamine may be a conditionally essential amino acid for critically ill patients, including preterm infants cared for in neonatal intensive care units (NICUs). In a randomized study of 68 very-low-birth-weight (VLBW) infants, we found evidence of lower morbidity in a group fed glutamine-supplemented preterm infant formula from postnatal day 3 to day 30 than in a group fed a standard formula. We report here the effects of the glutamine supplementation on hospital costs in these infants. Methods: The costs were analyzed by log-rank tests and Kaplan-Meier plots. Results: The median costs for hospitalization, radiology, pharmacy, laboratory, and the NICU, and the median number of utilization units were reduced with glutamine supplementation. Conclusions: This study provides the first evidence for decreased hospital costs in VLBW neonates who receive enteral glutamine supplementation. (Journal of Parenteral and Enteral Nutrition 22:352-356, 1998)

Get full access to this article

View all access options for this article.

References

Suzuki I. , Matsumoto Y. , Adjei AA , et al: Effect of a glutamine-supplemental diet on response to methicillin-resistant staphylococcus aureus infection in mice. J Nutr Sci Vitaminol 39:405-410, 1993

Yoshida S. , Yamasaki K. , Kaibera A. : Glutamine supplementation in septic rats. Nippon Geka-Gakki-Zasshi 94:1078-1085. 1993

Ziegler TR , Young LS , Benfell K. , et al: Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. Ann Intern Med 116:821-828, 1992

MacBurney M. , Young LS , Ziegler TR , et al: A cost-evaluation of glutamine-supplemented parenteral nutrition in adult bone marrow transplant patients. J Am Dietetic Assoc 94:1263-1266, 1994

Neu J. , Shenoy V. , Chakrabarti R. : Glutamine nutrition and metabolism: Where do we go from here? FASEB J 10:829-837, 1996

Neu J. , Roig JC , Meetze WH , et al: Enteral glutamine supplementation for very low birth weight infants decreases morbidity. J Pediatrics 131:691-699, 1997

Meetze WH , Valentine C. , McGuigan JE , et al: Gastrointestinal priming prior to full enteral in very low birth weight infants. J Pediatr Gastroenterol Nutr 15:163-170, 1992

Miller R. : Survival Analysis. John Wiley & Sons, New York, 1981, pp 1-2

Quesenberry CP , Fireman B. , Hiatt RA , et al: A survival analysis of hospitalization among patients with acquired immunodeficiency syndrome . Am J Public Health 79:1643-1647, 1989

10.

Hiatt RA , Quesenberry CP , Selby JV , et al: The cost of acquired immunodeficiency syndrome in Northern California: The experience of a large prepaid health plan. Arch Intern Med 150:833-838, 1990

11.

Fenn P. , McGuire A. , Phillips V. , et al: The analysis of censored treatment cost data in economic evaluation . Med Care 33:851-863, 1995

12.

Altman DG : Practical Statistics for Medical Research. Chapm & Hall, New York, 1991, pp 194, 368-375

13.

Lin DY , Feuer EJ , Etzioni R. , et al: Estimating medical costs from incomplete follow-up data. Biometrics 53:419-434, 1997

14.

Lacey JM , Wilmore DW : Is glutamine a conditionally essential amino acid? Nutr Rev 48:297-309, 1990

15.

Swails WS , Bell SJ , Borlase BC , et al: Glutamine content of whole proteins: Implications for enteral formulas. Nutr Clin Pract 7:77-80, 1992

16.

Lacey JM , Crouch JB , Benfell K. , et al: The effects of glutamine-supplemented parenteral nutrition in premature infants. JPEN 20:74-80, 1996